Kala Bio signs LOI for exclusive US distribution of Virotek ophthalmology genetic tests

PUBT · 1d ago
Kala Bio signs LOI for exclusive US distribution of Virotek ophthalmology genetic tests
  • Kala Bio signed a letter of intent with Virotek for an exclusive U.S. distribution and reseller partnership for ophthalmology genetic testing.
  • Kala would market and distribute the program to U.S. eye care channels; Virotek would run lab operations, kit fulfillment, processing, reporting.
  • Definitive agreements targeted within about 30 days; deal remains subject to corporate, regulatory, Nasdaq approvals.
  • Parties outlined a potential expansion into oncology, preventive health testing, telehealth channels, subject to mutual agreement.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kala Bio Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609010745PRIMZONEFULLFEED9819177) on September 01, 2026, and is solely responsible for the information contained therein.